Back to Search Start Over

High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype

Authors :
Nicole Golob-Schwarzl
Kira Bettermann
Anita Kuldeep Mehta
Sonja M. Kessler
Julia Unterluggauer
Stefanie Krassnig
Kensuke Kojima
Xintong Chen
Yujin Hoshida
Nabeel M. Bardeesy
Heimo Müller
Vendula Svendova
Michael G. Schimek
Clemens Diwoky
Alexandra Lipfert
Vineet Mahajan
Cornelia Stumptner
Andrea Thüringer
Leopold F. Fröhlich
Tatjana Stojakovic
K.P.R. Nilsson
Thomas Kolbe
Thomas Rülicke
Thomas M. Magin
Pavel Strnad
Alexandra K. Kiemer
Richard Moriggl
Johannes Haybaeck
Source :
Translational Oncology, Vol 12, Iss 2, Pp 256-268 (2019)
Publication Year :
2019
Publisher :
Elsevier, 2019.

Abstract

BACKGROUND & AIMS: Steatohepatitis (SH) and SH-associated hepatocellular carcinoma (HCC) are of considerable clinical significance. SH is morphologically characterized by steatosis, liver cell ballooning, cytoplasmic aggregates termed Mallory-Denk bodies (MDBs), inflammation, and fibrosis at late stage. Disturbance of the keratin cytoskeleton and aggregation of keratins (KRTs) are essential for MDB formation. METHODS: We analyzed livers of aged Krt18−/− mice that spontaneously developed in the majority of cases SH-associated HCC independent of sex. Interestingly, the hepatic lipid profile in Krt18−/− mice, which accumulate KRT8, closely resembles human SH lipid profiles and shows that the excess of KRT8 over KRT18 determines the likelihood to develop SH-associated HCC linked with enhanced lipogenesis. RESULTS: Our analysis of the genetic profile of Krt18−/− mice with 26 human hepatoma cell lines and with data sets of >300 patients with HCC, where Krt18−/− gene signatures matched human HCC. Interestingly, a high KRT8/18 ratio is associated with an aggressive HCC phenotype. CONCLUSIONS: We can prove that intermediate filaments and their binding partners are tightly linked to hepatic lipid metabolism and to hepatocarcinogenesis. We suggest KRT8/18 ratio as a novel HCC biomarker for HCC.

Details

Language :
English
ISSN :
19365233
Volume :
12
Issue :
2
Database :
Directory of Open Access Journals
Journal :
Translational Oncology
Publication Type :
Academic Journal
Accession number :
edsdoj.82f259d1149e4b69bf2a4846ca5d9eee
Document Type :
article
Full Text :
https://doi.org/10.1016/j.tranon.2018.10.010